ArticleNpj mental health research2025
A randomized controlled trial of an interactive digital therapeutic for stress and burnout management.
Article in Npj mental health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Professional burnout among dietitians and the perceived role of artificial intelligence tools.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This pragmatic randomized controlled trial examined the effectiveness of reviga, a self-guided digital intervention based on cognitive behavioral therapy, in reducing work-related stress symptoms. A total of 290 adults experiencing significant stress and burnout were assigned to the intervention group (reviga + treatment as usual [TAU]; n = 147) or the control group (TAU only; n = 143). Intent-to-treat analyses showed that 3 months post-randomization, participants in the intervention group experienced significant positive effects on the primary outcome, perceived stress (Cohen's d = 0.36), as well as on the secondary outcomes anxiety (d = 0.28), burnout (d = 0.31), occupational and social functioning (d = 0.31) and health-related quality of life (d = 0.35) compared to TAU. No effect was found for absenteeism quantified as the number of sick days. Effect sizes increased at 6 month follow-up. This study demonstrates that reviga represents a promising and scalable tool for workplace mental health support.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.